DPDPE (TFA)

• UNSPSC Description:

  DPDPE TFA, an opioid peptide, is a selective δ-opioid receptor (DOR) agonist with anticonvulsant effects[1].

• Target Antigen:

  Opioid Receptor

• Type:

  Peptides

• Related Pathways:

  GPCR/G Protein;Neuronal Signaling

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/dpdpe-tfa.html

• Purity:

  99.94

• Solubility:

  H2O : 50 mg/mL (ultrasonic)

• Smiles:

  OC(C=C1)=CC=C1C[C@H](N)C(N[C@@H]2C(C)(SSC(C)([C@@H](NC([C@@H](NC(CNC2=O)=O)CC3=CC=CC=C3)=O)C(O)=O)C)C)=O.O=C(O)C(F)(F)F

• Molecular Weight:

  759.81

• References & Citations:

  [1]F C Tortella, et al. Anticonvulsant Effects of Mu (DAGO) and Delta (DPDPE) Enkephalins in Rats. Peptides

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

• Clinical Information:

  No Development Reported

• CAS Number:

  172888-59-4